Analysts Are Bullish on Top Real Estate Stocks: Equity Residential (EQR), Lineage, Inc. (LINE)
There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Equity Residential (EQR) and Lineage, Inc. (LINE) with bullish sentiments.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Equity Residential (EQR)
Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on Equity Residential today and set a price target of $78.00. The company’s shares closed last Thursday at $65.76.
According to TipRanks.com, Goldfarb is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Equity Residential with a $71.16 average price target, an 8.2% upside from current levels. In a report issued on May 14, UBS also maintained a Buy rating on the stock with a $73.00 price target.
See today’s best-performing stocks on TipRanks >>
Lineage, Inc. (LINE)
RBC Capital analyst Michael Carroll maintained a Buy rating on Lineage, Inc. today and set a price target of $44.00. The company’s shares closed last Thursday at $40.05.
According to TipRanks.com, Carroll is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Lineage, Inc. with a $41.67 average price target, a 5.8% upside from current levels. In a report issued on May 9, TipRanks – DeepSeek also upgraded the stock to Buy with a $44.00 price target.
Read More on EQR:
Disclaimer & DisclosureReport an Issue
- Equity Residential Announces Merger with AvalonBay Communities
- AvalonBay, Equity Residential announce merger of equals
- AvalonBay, Equity Residential to combine in an all-stock merger of equals
- AvalonBay, Equity Residential near deal to combine, Bloomberg reports
- Equity Residential price target raised to $73 from $71 at UBS
